GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Corcept Therapeutics CORT · USD

Health Care · US listing · 🇺🇸 United States

Compare

75.03

+3.11%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
BLACKROCK, INC.12.2m10.13%+89.1k31 Mar 2026
BlackRock Institutional Trust Company, N.A.11m9.21%+112.4k31 Dec 2025
The Vanguard Group, Inc.9.5m7.89%−42.8k31 Dec 2025
INGALLS & SNYDER LLC7.6m6.34%+413.7k31 Mar 2026
Ingalls & Snyder LLC (Asset Management)7.2m6.00%−502.9k31 Dec 2025
Renaissance Technologies LLC5.8m4.80%−330.8k31 Dec 2025
RENAISSANCE TECHNOLOGIES LLC5.7m4.74%−75.7k31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC4.8m4.02%+4.8m31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC4.1m3.40%+4.1m31 Mar 2026
PARALLEL ADVISORS, LLC4m3.31%+98.3k31 Mar 2026
Parallel Advisors, LLC3.9m3.23%+7.7k31 Dec 2025
STATE STREET CORP3.2m2.67%+214.9k31 Mar 2026
FMR LLC3.2m2.66%+775.6k31 Mar 2026
State Street Investment Management (US)3m2.49%+15.7k31 Dec 2025
Belanoff (Joseph K)3m2.48%—24 Dec 2025

Insider trades

Purchases and sales by directors and officers, as filed with the regulator

DateWhoTypeSharesPriceValue
25 Mar 2026 ↗BELANOFF JOSEPH KChief Executive OfficerSale26.2k50.07$1.3m
20 Mar 2026 ↗Guyer WilliamChief Development OfficerSale11.8k36.01$423,730
17 Mar 2026 ↗BAKER G LEONARD JRDirectorPurchase100k33.14$3.3m
4 Mar 2026 ↗Guyer WilliamChief Development OfficerSale8.2k35.99$296,346

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

8.6m

+0.6% on the period before. 12.3 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

54.5%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 17 Sept 202670 shares
  • 3 Sept 202631,077 shares
  • 28 Aug 2026399 shares
  • 21 Aug 20261,245 shares
  • 17 Aug 20269,969 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.